Value-based Care in Type 2 Diabetes (Enhancing T2D Care)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Physician-patient quality circle.
- Who it may be relevant to
- Registry conditions: Diabetes Mellitus, Type 2. Basic parameters: 40 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Améliorer La Prise En Soins Et La Qualité De Vie Des Patients Diabétiques De Type 2 (Alliance DT2)
Overview
The aim of this study is to obtain a better glycemic index score (decrease) by improving the care and quality of life of type 2 diabetic patients for a possible remission of diabetes. This will be achieved through an intervention that includes a strategy for training primary care physicians and other healthcare professionals in patient therapeutic education (TPE), as well as group and/or individual TPE-related activities/tools made available to patients, funded and encouraged for individualized planning. Intervention follow-up will be carried out by means of quality-of-life questionnaires for patients who have undergone the new method, compared with patients who have received the usual care.
Interventions
- Behavioral Physician-patient quality circle
Intervention: (To be compared with standard care) 1. Interprofessionnal meeting per neighbourhood: (beforehand) Therapeutic patient education (TPE) training for healthcare professionals 2. Physician-patient quality circle t0 Group sessions (n= 3 to 6 patients) with doctor and therapeutic patient education specialist Clinical measurements - CM (incl. HbA1c, body composition, blood pressure). PROM evaluation questionnaires (EQ5D\&DIABQ) 3. Development of individualised T2D programme: with case ma
Primary outcome measures
- Glycated haemoglobin HbA1c (∆HbA1c) [Time frame: During 18 month]
Secondary outcome measures (4)
- Health-related quality of life (∆ EQ-5D-5L) [Time frame: During 18 months]
- Diabetes self-care behaviours measured by the Diabetes Intention, Attitude, and Behavior Questionnaire (∆ DIAB-Q) [Time frame: During 18 months]
- Fat/lean body mass (∆ body composition) [Time frame: During 18 months]
- Cost-effectiveness analysis [Time frame: At 12 and 18 months]
Eligibility criteria
Inclusion criteria
- Patients with newly diagnosed type 2 diabetes (less than 10 years)
- Age (between 40 and 65)
Exclusion criteria
- Significant comorbidities linked to worsening diabetes (such as renal failure, previous myocardial infarction, retinopathy, signs or symptoms of severe diabetic neuropathy or diabetic foot ulcers), severe osteoarthritis or as judged by the attending physician.
- Pregnant or breast-feeding women
- Persons who are unable to give signed informed consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Supportive care
Study locations
Center list to be confirmed — check the primary protocol.
Publications
- Ehlig D, Sapin M, Zeukeng MJ, Vogel J, Barthassat V, Favre B, DaCosta H, Tugay K, Coendoz-Carron S, Bumann D, Coclet J, Schaller P, Geissler A. Enhancing type 2 diabetes care by an individualized and group-based therapeutic patient education program: study protocol for a cluster randomized trial. Trials. 2025 Dec 23;26(1):577. doi: 10.1186/s13063-025-09302-x. PMID 41437100
Identifiers
NCT: NCT06774950 · 2024-01350 · SNCTP000006190